Company No: 16126355 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	31.12.2025
		£
Fixed assets
Investments	3	7,450
		7,450
Current assets
Debtors	4	3,875
Cash at bank and in hand		174
		4,049
Creditors: amounts falling due within one year	5	( 15,347)
Net current liabilities		(11,298)
Total assets less current liabilities		(3,848)
Net liabilities		( 3,848)
Capital and reserves
Called-up share capital	6	1
Profit and loss account		( 3,849 )
Total shareholder's deficit		( 3,848)

For the financial period ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The member has not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Single Eye Limited (registered number: 16126355) were approved and authorised for issue by the Director on 09 September 2026. They were signed on its behalf by:

Patrick Mayr Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Single Eye Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 107 Beaufort Street, London, SW3 6BA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

Reporting period length from 09 December 2024 to 31 December 2025 as the first period from incorporation was lengthened.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial assets
An asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

For financial assets carried at amortised cost, the amount of impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

	Period from 09.12.2024 to 31.12.2025
	Number
Monthly average number of persons employed by the Company during the period, including the director	1

3. Fixed asset investments

	Investments in joint ventures		Total
	£		£
Cost or valuation before impairment
At 09 December 2024	0		0
Additions	7,450		7,450
At 31 December 2025	7,450		7,450
Carrying value at 31 December 2025	7,450		7,450

4. Debtors

	31.12.2025
	£
Other debtors	3,875

5. Creditors: amounts falling due within one year

	31.12.2025
	£
Amounts owed to Group undertakings	12,046
Other creditors	3,301
	15,347

6. Called-up share capital

	31.12.2025
	£
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00	1

During the year 1 Ordinary share of £1 each was issued.

7. Related party transactions

Transactions with entities in which the entity itself has a participating interest

	31.12.2025
	£
Amounts owed to joint venture	12,046

The amount due to the joint venture represents a loan advanced from the joint venture to the Company. The loan is unsecured, interest-free and has no fixed repayment date or formal repayment terms.

Transactions with the entity's director

	31.12.2025
	£
Amounts owed by director	(3,875)

The amount due from the director represents an overdrawn director’s loan account. The balance is unsecured, interest-free, has no fixed repayment date and is repayable on demand.